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TOPIC: Highly efficient retrovirus-mediated gene transfer into hepatocytes in
vivo has been previously reported in the rat. Before considering human
applications of these techniques in the treatment of inherited liver diseases, it was
necessary to document its efficiency in a large animal model. Lamb was choosen
because the liver was similar to human liver regarding size and anatomy.
MATERIALS AND METHODS: To induce hepatocyte division which is necessary
for infection with retroviral particles, animals were subjected to a left
hepatectomy. Kinetics of liver regeneration were assessed on sequential liver
biopsies after partial hepatectomy in order to provide an evaluation of the peak of
maximal liver regeneration in a first animal group. Recombinant retroviruses
encoding a reporter gene (E. coli beta galactosidase) were then perfused through
the portal vein of the regenerating liver in a second animal group.
RESULTS: The more intense liver regeneration occurred from one to 6 days after
partial hepatectomy, with the highest thymidine kinase rate and MIB-1 antibody
staining on the second day. The proportion of genetically modified lamb
hepatocytes expressing the reporter gene was less than 1%, despite the use of
higher titers of retroviral particles than those described in previous reports.
CONCLUSION: The results obtained in rodent livers with this in vivo gene
transfer methodology cannot currently be scaled up in a large ruminant model.
The efficacy of vectors has to be tested in other large mammals before planning
gene therapy trials for the treatment of inherited liver diseases.
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